The lipid formulations of amphotericin B

Author： Herbrecht Raoul   Natarajan-Amé Shanti   Nivoix Yasmine   Letscher-Bru Valérie  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.8, 2003-08, pp. : 1277-1287

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amphotericin B formulations in invasive aspergillosis

By  

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and tissue distribution of amphotericin B following oral administration of three lipid-based formulations to rats

By Ibrahim Fady   Gershkovich Pavel   Sivak Olena   Wasan Ellen K.   Wasan Kishor M.  

Drug Development and Industrial Pharmacy, Vol. 39, Iss. 9, 2013-09 ,pp. : 1277-1283

Informa Healthcare

Access to resources Recommend Favorite

Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS ( R)), with commercial lipid-based formulations

By Fukui H.   Koike T.   Nakagawa T.   Saheki A.   Sonoke S.   Tomii Y.   Seki J.  

International Journal of Pharmaceutics, Vol. 267, Iss. 1, 2003-11 ,pp. : 101-112

Elsevier

Access to resources Recommend Favorite

Fatal Mix-up in amphotericin B formulations

By  

Inpharma, Vol. 1, Iss. 1605, 2007-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

New Formulations and Derivatives of Amphotericin B for Treatment of Leishmaniasis

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 2, 2006-02 ,pp. : 153-162

Bentham Science Publishers

Access to resources Recommend Favorite